Innovation is fundamental to the RxAdvisor™ Medication Management Platform. Our approach combines evidence-based medicine, scalable technology, strategic partnerships, and protected intellectual property to continuously expand the platform's capabilities while maintaining a seamless clinical experience.
An expanding portfolio of issued and pending U.S. patents protects key innovations in clinical decision support, treatment referral, adaptive deprescribing, and medication management—helping ensure that our technology remains differentiated as the platform evolves.
The RxAdvisor Platform is built on a modular architecture that allows new clinical capabilities to be developed, validated, and integrated without disrupting existing workflows. This flexible design enables healthcare organizations to adopt the modules they need today while expanding over time.
Strategic collaborations accelerate innovation and extend platform capabilities. Our partnership with Cliexa brings AI-enabled opioid use disorder (OUD) risk prediction into the RxAdvisor Platform using explainable, clinically validated technology, complementing our evidence-based clinical decision support tools.
Innovation is an ongoing process, not a one-time event. New capabilities—including Benefit-Risk Navigator™, TAPER™, TreatmentGPS™, and future platform enhancements—reflect our continued investment in helping healthcare organizations deliver safer prescribing, better outcomes, and coordinated care across the prescribing lifecycle.
MONITOR • PREDICT • OPTIMIZE • REDUCE RISK • CONNECT PATIENTS TO CARE